Canada Life’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-4,936
| Closed | -$88K | – | 2760 |
|
|
2020
Q2 | $88K | Hold |
4,936
| – | – | ﹤0.01% | 2080 |
|
|
2020
Q1 | $35K | Hold |
4,936
| – | – | ﹤0.01% | 2241 |
|
|
2019
Q4 | $117K | Buy |
+4,936
| New | +$136K | ﹤0.01% | 2040 |
|
|
2019
Q3 | – | Sell |
-6,833
| Closed | -$185K | – | 2647 |
|
|
2019
Q2 | $185K | Sell |
6,833
-661
| -9% | -$20.7K | ﹤0.01% | 2047 |
|
|
2019
Q1 | $259K | Hold |
7,494
| – | – | ﹤0.01% | 1814 |
|
|
2018
Q4 | $141K | Hold |
7,494
| – | – | ﹤0.01% | 2030 |
|
|
2018
Q3 | $200K | Hold |
7,494
| – | – | ﹤0.01% | 1981 |
|
|
2018
Q2 | $283K | Hold |
7,494
| – | – | ﹤0.01% | 1881 |
|
|
2018
Q1 | $245K | Hold |
7,494
| – | – | ﹤0.01% | 1902 |
|
|
2017
Q4 | $364K | Buy |
7,494
+1,696
| +29% | +$85.8K | ﹤0.01% | 1813 |
|
|
2017
Q3 | $311K | Hold |
5,798
| – | – | ﹤0.01% | 1836 |
|
|
2017
Q2 | $325K | Hold |
5,798
| – | – | ﹤0.01% | 1803 |
|
|
2017
Q1 | $227K | Hold |
5,798
| – | – | ﹤0.01% | 1898 |
|
|
2016
Q4 | $131K | Hold |
5,798
| – | – | ﹤0.01% | 2035 |
|
|
2016
Q3 | $131K | Hold |
5,798
| – | – | ﹤0.01% | 2037 |
|
|
2016
Q2 | $136K | Hold |
5,798
| – | – | ﹤0.01% | 1994 |
|
|
2016
Q1 | $118K | Hold |
5,798
| – | – | ﹤0.01% | 1685 |
|
|
2015
Q4 | $298K | Buy |
5,798
+2,198
| +61% | +$107K | ﹤0.01% | 1078 |
|
|
2015
Q3 | $154K | Hold |
3,600
| – | – | ﹤0.01% | 1397 |
|
|
2015
Q2 | $164K | Hold |
3,600
| – | – | ﹤0.01% | 1493 |
|
|
2015
Q1 | $136K | Hold |
3,600
| – | – | ﹤0.01% | 1589 |
|
|
2014
Q4 | $102K | Hold |
3,600
| – | – | ﹤0.01% | 1739 |
|
|
2014
Q3 | $91K | Buy |
+3,600
| New | +$94.8K | ﹤0.01% | 1762 |
|
Canada Life's PTLA Position: Q3 2020 in Review
Canada Life sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 4,936 shares — an estimated $88K sold.
Canada Life first reported a position in PTLA in Q3 2014 and held it in 23 quarters. The position peaked at $364K in Q4 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Canada Life reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Canada Life sold 4,936 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $88K.
- Canada Life first reported a position in Portola Pharmaceuticals, Inc. in Q3 2014 and held it in 23 quarters.
- Canada Life's Portola Pharmaceuticals, Inc. position peaked at $364K in Q4 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Canada Life's 13F filing for Q3 2020, filed 13 Nov 2020.